Plus Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

Go back to Plus Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

Plus Therapeutics, Inc. (PSTV) Misses Q2 EPS by 1c

July 21, 2022 4:08 PM EDT

Plus Therapeutics, Inc. (NASDAQ: PSTV) reported Q2 EPS of ($0.24), $0.01 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Plus Therapeutics, Inc. (PSTV) click here.

... More